EFPIA - NEWSLETTER

Trouble reading this email? View it in your browser


		EFPIA Newsletter 30 April 2026

Blogs

EU Biotech Act: how to turn innovation into impact (Guest blog)
30 April 2026

Innovative biotechnologies bring real promise for patients in Europe, but they are complex to develop, test, and manufacture.... Read more

Europe’s Choice: The value of investing in innovation

Europe stands at a crossroads. In a world shaped by geopolitical tensions, economic fragmentation and accelerating global competition, the choices made today will determine Europe’s ability to compete, innovate and lead in the decades ahead.

Join us on 23 June in Brussels to engage in a forward-looking discussion on how Europe can turn today’s challenges into opportunities – and make the right choices for its future.

Register here.

Events

Towards comprehensive cardiovascular health checks across Europe
07 May 2026 (Brussels, Belgium)

Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity in Europe, despite significant advances... Read more

Unlocking Europe’s Life Science potential: A policy agenda for competitiveness, innovation...
08 May 2026 (The Landmark Nicosia, Cyprus)

Europe stands at a critical moment for its life sciences sector. Across the world, governments are actively strengthening... Read more

European Pharmaceutical Law Forum
19 May 2026 (Brussels, Belgium)

The European pharmaceutical market is facing a moment of profound change. With sweeping updates to the EU pharmaceutical... Read more

Inaugural Forum on Life Sciences Product Liability, Policy & Dispute Resolution Europe
17 June 2026 (Brussels, Belgium)

The must-attend European defense strategy forum for the life sciences litigation community. Europe’s Premier Forum for... Read more

What we are reading

Shielding Europe against vaccine-preventable cancers
On 24 April 2026 (Vaccines Today)

European countries are working together to protect people against cancers – including cervical and liver cancers... Read more

History of vaccines
On 20 April 2026 (University of Oxford)

Across more than two centuries, vaccines have evolved from simple observations into highly engineered and safe medical... Read more

About the EFPIA newsletter

The European Federation of Pharmaceutical Industries and Associations (EFPIA) represents the pharmaceutical industry operating in Europe. Through its direct membership of 37 national associations and 40 leading pharmaceutical companies, EFPIA is the voice on the EU scene of 1,900 companies committed to researching, developing and bringing to patients new medicines that will improve health and the quality of life around the world.

Tel: +32 (0)2 626 25 55
E-mail:Communications@efpia.eu